Terayon Communication Systems Aktie
WKN DE: 916006 / ISIN: US8807751016
06.08.2025 00:40:03
|
Terns Pharmaceuticals, Inc. Loss At -$24.09 Mln In Q2
(RTTNews) - Terns Pharmaceuticals, Inc. (TERN) released Loss for second quarter of -$24.09 million
The company's bottom line came in at -$24.09 million, or -$0.26 per share. This compares with -$22.73 million, or -$0.31 per share, last year.
Terns Pharmaceuticals, Inc. earnings at a glance (GAAP) :
-Earnings: -$24.09 Mln. vs. -$22.73 Mln. last year. -EPS: -$0.26 vs. -$0.31 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Terayon Communication Systems Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |